Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARAME pre-pilot study of targeted antibacterial antibody development
NL-OMON44672Recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2015
- Modality
- Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of anti-Escherichia coli recombinant antibodies and anti-Pseudomonas aeruginosa recombinant antibodies in sepsis, bloodstream infection (BSI) and Pseudomonas Sepsis (2 cohorts), sponsored by Erasmus MC. Started Oct 2015; status: recruiting.
02
Drugs
anti-Escherichia coli recombinant antibodiesanti-Pseudomonas aeruginosa recombinant antibodies
03
Conditions
sepsisbloodstream infection (BSI)Pseudomonas Sepsis
Beyond the preview
Go deeper on NL-OMON44672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44672.